AIM IMMUNOTECH INC. Debt Instrument, Fee Amount
AIM IMMUNOTECH INC. (AIM) had Debt Instrument, Fee Amount of $6.27 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFeeAmount · last filed 2023-11-14
- 2023-09-30: Debt Instrument, Fee Amount $6.27K.
- 2023-06-30: Debt Instrument, Fee Amount $168.00.
- 2023-03-31: Debt Instrument, Fee Amount $15.00.
| Period end | Debt Instrument, Fee Amount |
|---|---|
| 2023-09-30 | $6.27K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $168.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $15.00 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |